We detected a similar breadth of the CD4+ T‐cell response in terms of the number of peptides recognised in unvaccinated COVID‐19 patients, vaccinated individuals (‘V2/V3’) and patients with a combination of vaccination and infection (‘IV/VI’) (Figure 1b). This evidence concerns the gene CD4 and COVID-19.